Affordable Access

deepdyve-link
Publisher Website

Biomarkers to detect rejection after kidney transplantation.

Authors
  • Dharnidharka, Vikas R1
  • Malone, Andrew2
  • 1 Division of Pediatric Nephrology, Hypertension and Pheresis, Washington University in St Louis & St. Louis Children's Hospital, St Louis, MO, USA. [email protected]
  • 2 Division of Nephrology, Washington University School of Medicine, St Louis, MO, USA.
Type
Published Article
Journal
Pediatric Nephrology
Publisher
Springer-Verlag
Publication Date
Jun 19, 2017
Identifiers
DOI: 10.1007/s00467-017-3712-6
PMID: 28631040
Source
Medline
Keywords
License
Unknown

Abstract

Detecting acute rejection in kidney transplantation has been traditionally done using histological analysis of invasive allograft biopsies, but this method carries a risk and is not perfect. Transplant professionals have been working to develop more accurate or less invasive biomarkers that can predict acute rejection or subsequent worse allograft survival. These biomarkers can use tissue, blood or urine as a source. They can comprise individual molecules or panels, singly or in combination, across different components or pathways of the immune system. This review highlights the most recent evidence for biomarker efficacy, especially from multicenter trials.

Report this publication

Statistics

Seen <100 times